A nasal spray formulation of bumetanide has been shown to be safe and effective in a new study and could ultimately prevent ...
New research highlights nasal spray drug’s potential to counter Alzheimer’s by targeting brain enzyme dysfunction.
Neffy, a new epinephrine nasal spray, offers a less invasive option for treating allergic reactions. Learn about its benefits ...
A study conducted bà Cattolica in Rome and the Fondazione Policlinico Universitario Agostino Gemelli IRCCS has uncovered a ...
Bumetanide nasal spray (BNS) has statistical bioequivalence to oral bumetanide, according to a research letter publish ...
A potential new treatment for Alzheimer’s disease may come in the form of a nasal spray. Researchers in Italy have discovered ...
A future treatment for Alzheimer disease may involve a nasal spray. Researchers at Università Cattolica and Fondazione ...
An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at Texas A&M University College of Medicine. Alzheimer's is the most common ...
A future treatment for Alzheimer disease may involve a nasal spray. Researchers at Università Cattolica and Fondazione Policlinico Universitario A. Gemelli IRCCS have discovered that by inhibiting the ...
Although ARS Pharmaceuticals’ approval for its epinephrine nasal spray came later than expected, the company ultimately received a thumbs up from the FDA in August and is now moving fast to ...
Some nasal sprays contain oxymetazoline, a drug designed to shrink the blood vessels in the nose, helping it feel less congested. Although cold sores are most common around the mouth, they can ...